MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$510.04
-24.82 (-4.64%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
-76.5% upside
Low Target
$78.20
Average Target
$119.83
High Target
$127.79
Current Price
$510.04
Current
$510.04
$510.04
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Scenario Analysis
Bear Case
$78.20
-84.7%
Low target
Base Case
$119.83
-76.5%
Avg target
Bull Case
$127.79
+-74.9%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$615.00
-17.1% from high
52-Week Low
$265.00
+92.5% from low
50-Day SMA
$526.21
-3.1% vs SMA
200-Day SMA
$421.32
+21.1% vs SMA
RSI (14)
32.6
Neutral
Target vs 52W High
$119.83
-80.5% vs high
Next Earnings Report
May 12, 2026 · Before Market Open
Today
EPS Est: $-4.31
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |